Nielsen Gitte Blach, Haugegaard John, Jolie Rika
MSD Animal Health Nordics, Havneholmen 25, DK-1561 Copenhagen V, Denmark.
Merck Animal Health, 2 Giralda Farms, Madison, NJ 07940 USA.
Porcine Health Manag. 2018 Dec 7;4:29. doi: 10.1186/s40813-018-0104-7. eCollection 2018.
In practice, field evaluation of vaccine efficacy in individual herds is often based on a historical comparison of productivity data following initiation of vaccination. Being biased by time, this study design highly contrasts the more controlled, parallel-group design used for most initial vaccine efficacy studies but offers the possibility of including a larger number of animals and herds. As an important add-on to previous findings in controlled studies, the objective of this study was to evaluate the field efficacy of the ready-to-use combination vaccine Porcilis® PCV M Hyo (MSD Animal Health) by an observational historical study design using routinely generated herd productivity data.
Data on mortality, average daily weight gain and feed conversion rate were collected as yearly averages for one year prior to and one year after implementation of Porcilis® PCV M Hyo vaccination from 20 nursery and 23 finishing herds. When comparing pre- and post-vaccination periods, the average improvements in productivity data amounted to - 0.4 percentage points for mortality ( = 0.014), + 5 g for average daily weight gain ( = 0.555) and - 0.06 feeding units(FU)/kg for feed conversion rate ( = 0.074) in nursery herds and - 0.5 percentage points for mortality ( = 0.012), + 34 g for average daily weight gain ( < 0.001) and - 0.04 FU/kg for feed conversion rate ( = 0.133) in finishing herds. Even though some nursery and finishing herds also previously vaccinated against PCV2 and/or , this did not significantly affect the results. For finishers, these results were obtained when difference in arrival weights between the periods and shared ownership of the herds were additionally taken into account.
In these 20 nursery and 23 finishing herds, previous findings from parallel-group vaccination studies concerning average daily weight gain for finishers were confirmed. Additionally, a significant effect on mortality for both nursery and finishing herds was demonstrated in this evaluation based on routinely generated herd productivity data.
在实际操作中,对单个畜群疫苗效力的现场评估通常基于接种疫苗后生产力数据的历史比较。由于受时间因素的影响,这种研究设计与大多数初始疫苗效力研究所采用的更具控制性的平行组设计形成了鲜明对比,但它提供了纳入更多动物和畜群的可能性。作为对以往对照研究结果的重要补充,本研究的目的是通过一项观察性历史研究设计,利用常规生成的畜群生产力数据,评估即用型组合疫苗Porcilis® PCV M Hyo(默克动物保健公司)的现场效力。
收集了20个保育畜群和23个育肥畜群在接种Porcilis® PCV M Hyo疫苗前一年和后一年的死亡率、平均日增重和饲料转化率的年度平均数据。在比较接种疫苗前后的时期时,保育畜群的生产力数据平均改善情况为:死亡率降低-0.4个百分点(P = 0.014),平均日增重增加+5克(P = 0.555),饲料转化率降低-0.06饲料单位(FU)/千克(P = 0.074);育肥畜群的情况为:死亡率降低-0.5个百分点(P = 0.012),平均日增重增加+34克(P < 0.001),饲料转化率降低-0.04 FU/千克(P = 0.133)。尽管一些保育畜群和育肥畜群之前也接种过针对PCV2和/或其他疾病的疫苗,但这并未对结果产生显著影响。对于育肥畜群,在额外考虑不同时期的入栏体重差异和畜群的共同所有权后获得了这些结果。
在这20个保育畜群和23个育肥畜群中,平行组疫苗接种研究中关于育肥畜群平均日增重的先前发现得到了证实。此外,基于常规生成的畜群生产力数据进行的本次评估表明,对保育畜群和育肥畜群的死亡率均有显著影响。